Aexa Aerospace Demonstrates Holographic Teleportation for Telemedicine Applications

HOUSTON / ACCESSWIRE / July 27, 2020 / ​Aexa Aerospace, a NASA contractor and developer of the HoloWizard augmented reality application for support to real-time operations, has further enhanced the “holoportation” capabilities they previously developed.

This demonstration focuses on the utility of holoportation to remotely administer part of a stroke exam, and to coach the proper technique for physical therapy.

The demonstration illustrates the many possibilities for telemedicine support using this powerful holoportation technique.

Holoportation uses secure encrypted communication.

For more information, please visit https://aexa.com.

Media Contact:
Karen Gress
Phone: 713.260.9624
Email: karengress@aexa.us

Related Images

Related Links

Aexa Aerospace

Related Video

SOURCE: Aexa Aerospace

View source version on accesswire.com:
https://www.accesswire.com/598973/Aexa-Aerospace-Demonstrates-Holographic-Teleportation-for-Telemedicine-Applications

Staff

Recent Posts

CannaPharmaRX Provides Corporate Update and Outlines Growth Strategy for 2026

CALGARY, AB / ACCESS Newswire / January 12, 2026 / CannaPharmaRX, Inc. (OTC PINK:CPMD), an…

11 hours ago

TempraMed Closes C$2.5 Million Fully Subscribed Private Placement

Vancouver, British Columbia--(Newsfile Corp. - January 12, 2026) - TempraMed Technologies Ltd. (CSE: VIVI) (FSE:…

14 hours ago

TruuCONNECT NJ Statewide Digital Hub Empowers Users to Find Verified, Local Community Resources and Support – Anonymously and in Real Time

MOUNT LAUREL, N.J., Jan. 12, 2026 /PRNewswire/ -- Born out of a partnership between the…

14 hours ago

Nuvo Unveils Large-Scale AI-Ready Pregnancy Dataset Built on Real-World Maternal and Fetal Physiology

Unique longitudinal dataset combining native fetal and maternal ECG with phonocardiography supports deeper insights into…

14 hours ago

Alamar Biosciences Announces Launch of NULISAqpcr™ AD 5-plex Assay, Advancing Blood Based Biomarker Detection in Alzheimer’s Disease Research

FREMONT, Calif., Jan. 12, 2026 /PRNewswire/ -- Alamar Biosciences, Inc. ("Alamar"), a leader in precision…

14 hours ago

RxAnte Announces Strategic Growth Investment from Primus Capital

PORTLAND, Maine, Jan. 12, 2026 /PRNewswire/ -- RxAnte, the leading provider of analytics, software, and…

14 hours ago